Can combining different risk interventions into a single formulation contribute to improved cardiovascular disease risk reduction? Rationale and design for an international, open-label program to assess the effectiveness of a single pill (amlodipine/atorvastatin) to attain recommended target levels for blood pressure and lipids (The JEWEL Program)

✍ Scribed by F.D. Richard Hobbs; Gianfranco Gensini; G.B. John Mancini; Athanasios J. Manolis; Beverly Bauer; Steffen Böhler; Jacques Genest; Ross Feldman; Peter Harvey; Trond G. Jenssen; Michael Metcalfe; Pedro Marques da Silva

• Book ID: 116544404
• Publisher: Elsevier Science
• Year: 2006
• Tongue: English
• Weight: 242 KB
• Volume: 110
• Category: Article
• ISSN: 0167-5273
• DOI: 10.1016/j.ijcard.2005.10.017